Hemostatic Agents Market Size and Trends Worth US$ 5441.5 Mn at 6.4% CAGR by 2025 | Exclusive Report by Fortune Business Insights

The Hemostatic Agents Market to gain from increasing number of surgical procedures conducted worldwide. A new report is published by Fortune Business Insights that anticipated to expand at a CAGR of 6.4% and reach US$ 5441.5 Mn by the end of 2025.

Pune, India - May 16, 2019 /MarketersMedia/ —

The Global Hemostatic Agents Market to gain from increasing number of surgical procedures conducted worldwide. A new report is published by Fortune Business Insights, titled “Hemostatic Agents Market Size, Share and Global Trend By Product Type (Active Hemostats, Passive Hemostats, Combination Hemostats), Application (Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery & Neurosurgery), End User (Hospitals, Ambulatory Surgical Centers, Tactical Combat Casualty Care Centers) and Geography Forecast till 2025.” As per the report, in 2017 the global hemostatic agents market was worth US$ 3339.4 Mn. The global market is anticipated to expand at a CAGR of 6.4% and reach US$ 5441.5 Mn by the end of 2025.

The hemostatic agents market in Asia Pacific is expected to grow at a relatively higher CAGR. Baxter (the leading organization in global market), plans to expand its operation in emerging nations such as India and China to enhance its accessibility. This is expected to propel the growth rate of the Asia Pacific hemostatic agents market. Meanwhile, the Europe market is likely to expand at a low CAGR due to the presence of a smaller patient pool compared to Asia Pacific and North America.

Request sample copy at https://www.fortunebusinessinsights.com/enquiry/sample/hemostatic-agents-market-100084

The report classifies the global hemostatic agents market in terms of various segments and offers a comprehensive overview. According to the report the hemostatic agents market in North America was valued at US$ 1173 Mn in 2017. The North America market was leading at a global sphere in the same year. According to the report, the trend is unlikely to change during the forecast period 2018-2025. Growth the market witnessed in North America is attributable to the increasing demand for surgical procedure in the region. Besides this, as per a research conducted by the American College of Obstetricians and Gynecologist, in the U.S. the rate of postpartum hemorrhage increased by 25.9% approximately during the last decade. This is likely to fuel the demand for hemostatic agents for surgery and other purposes

Combination Hemostats to Dominate the Global Market

In terms of product type, the combination hemostats segment accounted for 14% of the global market in 2017. Combination hemostats are proven to be very effective and offer faster healing. Combination hemostats are capable of offering efficient hemostasis in shorter time owing to rapid action of thrombin and gelatin. Rising adoption of combination hemostats is anticipated to drive the global hemostatic agents market during the forecast period 2018-2025.

The factors expected to drive the global hemostatic agents market are increasing incidence of hemorrhage during surgery and rising emphasis on blood management. Moreover, innovations in surgical procedure such as robot assisted surgery and rising geriatric population are anticipated to fuel the demand in global hemostatic agents market.

As per data published by the Journal of medical Emergency Services (JEMS), worldwide approximately 5 million people die due to traumatic and non-traumatic hemorrhage. Therefore, the rising cases of traumatic or non-traumatic hemorrhage is likely to enable growth in the global hemostatic agents market.

Baxter Widening its Distribution Network Across Regions

Baxter emerged dominant in the global hemostatic agents market in 2017. The growth witnessed is attributable to its diversification strategy implemented to improve the accessibility of its brands. The trend is unlikely to change and Baxter may continue to dominate the global market during forecast period. Strong brand presence, diversified product portfolio, and intense R&D conducted on hemostatic agents are a few factor contributing to Baster’s expansion. Some of the other companies operating in the global hemostatic agents market are Stryker, CryoLife Inc., Integra Life Sciences, BD, Ethicon LLC., Pfizer Inc., Medtronic, and Biom’up.

Browse Complete Report Details at https://www.fortunebusinessinsights.com/industry-reports/hemostatic-agents-market-100084

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Info:
Name: Fortune Business Insights
Email: Send Email
Organization: Fortune Business Insights
Address: Fortune Business Insights Pvt. Ltd. 308, Supreme Headquarters, Survey No. 36, Baner, Pune-Bangalore Highway, Pune - 411045, Maharashtra, India.
Phone: 1 424 253 0390
Website: https://www.fortunebusinessinsights.com

Source URL: https://marketersmedia.com/hemostatic-agents-market-size-and-trends-worth-us-54415-mn-at-64-cagr-by-2025-exclusive-report-by-fortune-business-insights/513423

Source: MarketersMedia

Release ID: 513423

Latest News

Stocks rise as China confirms trade deal signing next week

May 25, 2020

NEW YORK — U.S stocks climbed in morning trading on Thursday as investors cheered confirmation from China that its top trade official will head to Washington next week to sign a preliminary trade deal. The “Phase 1” accord is the opening step on a possible path toward a broader agreement between the nations. President Donald Trump has said he will travel to Beijing after the initial signing to start the second stage of talks. Every major index is on track for a record as Wall Street distances itself from a bout of anxiety over the last week because of tensions...

China, Japan stocks lower on Christmas

May 25, 2020

Chinese and Japanese stocks declined Thursday while most other Asian markets were closed for Christmas Day. Tokyo's Nikkei 225 lost 0.1% to 23,806.72 while the Shanghai Composite Index was off 2 points at 2,982.80. Malaysia's benchmark was down 0.6% while Taiwan gained nine points. Wall Street ended nearly flat Tuesday in a shortened trading session before closing for Christmas Day. U.S. markets reopen Thursday. The benchmark S&P 500 index slipped less than 0.1% to 3,223.38. The Dow Jones Industrial Average dropped 0.1%, to 28,515.45. The Nasdaq composite gained 0.1% to 8,952.88. Investors have been encouraged by plans for an interim...

House passes $1.4T government spending bill amid impeachment

May 25, 2020

WASHINGTON — The Democratic-controlled House voted Tuesday to pass a $1.4 trillion government spending package, handing President Donald Trump a victory on his U.S.-Mexico border fence while giving Democrats spending increases across a swath of domestic programs. The hard-fought legislation also funds a record Pentagon budget and is serving as a must-pass legislative locomotive to tow an unusually large haul of unrelated provisions into law, including an expensive repeal of Obama-era taxes on high-cost health plans, help for retired coal miners, and an increase from 18 to 21 in the nationwide legal age to buy tobacco products. The two-bill package,...

Stocks rise on Wall Street as rally stretches to fourth day

May 25, 2020

NEW YORK — U.S. stocks rallied Monday, rising with European and several Asian markets following surprisingly strong reports on China's economy. Growth in factory activity and retail sales in the world's second-largest economy both beat analysts’ expectations for last month. That layered on top of optimism from last week’s long-awaited “Phase 1” trade deal between China and the United States, which removed some of the uncertainty that’s hung over businesses and investors. The interim trade deal is one of a “trifecta of positive catalysts” that swept through the market last week and could help support it through the end of...

Draghi stepped in during euro's darkest hour

May 25, 2020

FRANKFURT, Germany — Mario Draghi leaves as head of the European Central Bank credited with having rescued the eurozone from disaster with a well-timed phrase and bold action to back up his words. He expanded the bank's arsenal of crisis-fighting tools with new and unconventional policies, measures that he and others say helped end a financial crisis in 2010-2012 and create millions of jobs in the 19-country monetary union. Yet the closing days of his term have hardly been a victory lap. His departure is accompanied by an unusually public dispute among ECB board members over stimulus policies he pushed...

Broaden News
Search

Manage The Numbers is the world’s fastest-growing finance news website, featuring the latest money and market news, along with in-depth analysis so you can make the best decision.

Contact us: sales@managethenumbers.com

Subscribe to our newsletter!

Name

Email